Mallinckrodt Pharmaceuticals
MNK
#10252
Rank
โ‚ฌ4.12 M
Marketcap
0,31ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Mallinckrodt Pharmaceuticals (MNK)

EPS in 2023 (TTM): -114,15ย โ‚ฌ

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -110,45ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -7,73ย โ‚ฌ an increase over its 2020 EPS that were of -10,21ย โ‚ฌ.

EPS history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-114,15ย โ‚ฌ
2021-7,73ย โ‚ฌ-24.31%
2020-10,21ย โ‚ฌ-5.41%
2019-10,79ย โ‚ฌ-72.67%
2018-39,49ย โ‚ฌ-291.46%
201720,62ย โ‚ฌ797.22%
20162,30ย โ‚ฌ-34.03%
20153,48ย โ‚ฌ-207.61%
2014-3,24ย โ‚ฌ-366.73%
20131,21ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
12,85ย โ‚ฌ-111.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,82ย โ‚ฌ-98.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
7,80ย โ‚ฌ-107.06%๐Ÿ‡บ๐Ÿ‡ธ USA